What happened
D&D Pharmatech disclosed convertible bonds to raise US$154M, about 11.1% of its market value.
For context, this raise equals about 11.1% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$154M |
| vs. market value | 11.1% |
| Filed | 2026-04-15, Material event report (convertible bonds) |
| Source | DART rcept 20260415000050 → open original filing |
Source: DART. Information only, not investment advice.